The NPC lysosomal pathway as a novel hub in host: pathogen interactions

A single protein, NPC1, that fails in a rare childhood disease turns out to be the very same molecule that tuberculosis bacteria and Ebola virus hijack to survive inside human cells. This discovery reframes a fundamental question in infection biology. For decades, researchers have studied how pathogens invade cells, but they have largely overlooked the lysosome—a compartment that normally breaks down waste and stores calcium. The team found that multiple unrelated pathogens have independently evolved ways to commandeer NPC1, suggesting it is a central weak point in human defences. Understanding exactly how these microbes manipulate the protein could reveal why some people are more susceptible to certain infections and why inflammation sometimes spirals out of control. This is primarily fundamental science. The immediate payoff is a deeper understanding of how pathogens exploit a core cellular machine. If the work succeeds, it could open a new route for designing drugs that block infection by protecting NPC1, rather than attacking the pathogen directly. Similar fundamental insights into lysosomal biology have already led to treatments for Gaucher’s disease and Fabry disease. Here, the same pathway might eventually yield broad-spectrum antivirals or anti-inflammatory therapies—but that depends on first mapping the molecular choreography between pathogen and protein.